160 related articles for article (PubMed ID: 7779774)
21. C1s, the protease messenger of C1. Structure, function and physiological significance.
Gál P; Ambrus G; Závodszky P
Immunobiology; 2002 Sep; 205(4-5):383-94. PubMed ID: 12396001
[TBL] [Abstract][Full Text] [Related]
22. NH2-terminal calcium-binding domain of human complement C1s- mediates the interaction of C1r- with C1q.
Busby TF; Ingham KC
Biochemistry; 1990 May; 29(19):4613-8. PubMed ID: 2372546
[TBL] [Abstract][Full Text] [Related]
23. Importance of the prime subsites of the C1s protease of the classical complement pathway for recognition of substrates.
O'Brien G; Quinsey NS; Whisstock JC; Pike RN
Biochemistry; 2003 Dec; 42(50):14939-45. PubMed ID: 14674770
[TBL] [Abstract][Full Text] [Related]
24. Domain structure, stability, and interactions of human complement C1s-: characterization of a derivative lacking most of the B chain.
Busby TF; Ingham KC
Biochemistry; 1988 Aug; 27(16):6127-35. PubMed ID: 2847785
[TBL] [Abstract][Full Text] [Related]
25. Domain structure and associated functions of subcomponents C1r and C1s of the first component of human complement.
Villiers CL; Arlaud GJ; Colomb MG
Proc Natl Acad Sci U S A; 1985 Jul; 82(13):4477-81. PubMed ID: 2989825
[TBL] [Abstract][Full Text] [Related]
26. A molecular dynamics study of C1r and C1s dimers: implications for the structure of the C1 complex.
Beveridge AJ; Wallis R; Samani NJ
Proteins; 2012 Aug; 80(8):1987-97. PubMed ID: 22488778
[TBL] [Abstract][Full Text] [Related]
27. Assembly and enzymatic properties of the catalytic domain of human complement protease C1r.
Lacroix M; Ebel C; Kardos J; Dobó J; Gál P; Závodszky P; Arlaud GJ; Thielens NM
J Biol Chem; 2001 Sep; 276(39):36233-40. PubMed ID: 11445589
[TBL] [Abstract][Full Text] [Related]
28. Recombinant human complement subcomponent C1s lacking beta-hydroxyasparagine, sialic acid, and one of its two carbohydrate chains still reassembles with C1q and C1r to form a functional C1 complex.
Luo C; Thielens NM; Gagnon J; Gal P; Sarvari M; Tseng Y; Tosi M; Zavodszky P; Arlaud GJ; Schumaker VN
Biochemistry; 1992 May; 31(17):4254-62. PubMed ID: 1533159
[TBL] [Abstract][Full Text] [Related]
29. The structure and function of the first component of complement: genetic engineering approach (a review).
Gál P; Cseh S; Schumaker VN; Závodszky P
Acta Microbiol Immunol Hung; 1994; 41(4):361-80. PubMed ID: 7866721
[TBL] [Abstract][Full Text] [Related]
30. Activation of the classical complement pathway by mannose-binding protein in association with a novel C1s-like serine protease.
Matsushita M; Fujita T
J Exp Med; 1992 Dec; 176(6):1497-502. PubMed ID: 1460414
[TBL] [Abstract][Full Text] [Related]
31. Elucidation of the substrate specificity of the C1s protease of the classical complement pathway.
Kerr FK; O'Brien G; Quinsey NS; Whisstock JC; Boyd S; de la Banda MG; Kaiserman D; Matthews AY; Bird PI; Pike RN
J Biol Chem; 2005 Nov; 280(47):39510-4. PubMed ID: 16169853
[TBL] [Abstract][Full Text] [Related]
32. Complement C2 receptor inhibitor trispanning and the beta-chain of C4 share a binding site for complement C2.
Inal JM; Schifferli JA
J Immunol; 2002 May; 168(10):5213-21. PubMed ID: 11994478
[TBL] [Abstract][Full Text] [Related]
33. Structure and functions of the interaction domains of C1r and C1s: keystones of the architecture of the C1 complex.
Thielens NM; Bersch B; Hernandez JF; Arlaud GJ
Immunopharmacology; 1999 May; 42(1-3):3-13. PubMed ID: 10408360
[TBL] [Abstract][Full Text] [Related]
34. The structure of C2b, a fragment of complement component C2 produced during C3 convertase formation.
Krishnan V; Xu Y; Macon K; Volanakis JE; Narayana SV
Acta Crystallogr D Biol Crystallogr; 2009 Mar; 65(Pt 3):266-74. PubMed ID: 19237749
[TBL] [Abstract][Full Text] [Related]
35. Role of the distal hinge region of C1-inhibitor in the regulation of C1s activity.
He S; Yang JC; Tsang S; Sim RB; Whaley K
FEBS Lett; 1997 Aug; 412(3):506-10. PubMed ID: 9276455
[TBL] [Abstract][Full Text] [Related]
36. Partial sequence of human complement component factor B: novel type of serine protease.
Christie DL; Gagnon J; Porter RR
Proc Natl Acad Sci U S A; 1980 Aug; 77(8):4923-7. PubMed ID: 6776529
[TBL] [Abstract][Full Text] [Related]
37. Characterization of zero-length cross-links between rabbit skeletal muscle troponin C and troponin I: evidence for direct interaction between the inhibitory region of troponin I and the NH2-terminal, regulatory domain of troponin C.
Leszyk J; Grabarek Z; Gergely J; Collins JH
Biochemistry; 1990 Jan; 29(1):299-304. PubMed ID: 2108719
[TBL] [Abstract][Full Text] [Related]
38. The structure of MBL-associated serine protease-2 reveals that identical substrate specificities of C1s and MASP-2 are realized through different sets of enzyme-substrate interactions.
Harmat V; Gál P; Kardos J; Szilágyi K; Ambrus G; Végh B; Náray-Szabó G; Závodszky P
J Mol Biol; 2004 Oct; 342(5):1533-46. PubMed ID: 15364579
[TBL] [Abstract][Full Text] [Related]
39. A 100-kDa protein in the C4-activating component of Ra-reactive factor is a new serine protease having module organization similar to C1r and C1s.
Takayama Y; Takada F; Takahashi A; Kawakami M
J Immunol; 1994 Mar; 152(5):2308-16. PubMed ID: 8133044
[TBL] [Abstract][Full Text] [Related]
40. Outer surface lipoproteins from the Lyme disease spirochete exploit the molecular switch mechanism of the complement protease C1s.
Garrigues RJ; Thomas S; Leong JM; Garcia BL
J Biol Chem; 2022 Nov; 298(11):102557. PubMed ID: 36183830
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
